Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4.10M | $4.0M | 9.73% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 382.5K | -- | 0.91% | -- | 2026-03-31 |
| WELLS FARGO & COMPANY/MN | 264.4K | -- | 0.63% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 157.5K | -- | 0.37% | +47.7K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 64.9K | -- | 0.15% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 62.8K | -- | 0.15% | -59.7K | 2026-03-31 |
| STATE STREET CORP | 43.3K | -- | 0.10% | -- | 2026-03-31 |
| BlackRock, Inc. | 39.9K | -- | 0.09% | +13.4K | 2026-03-31 |
| NORTHERN TRUST CORP | 19.6K | -- | 0.05% | -- | 2026-03-31 |
| US BANCORP \DE\ | 16.9K | -- | 0.04% | -- | 2026-03-31 |
